Thomas Roehrig - Quipt Home Executive Finance
| QIPT Stock | 4.88 0.01 0.21% |
Executive
Thomas Roehrig is Executive Finance of Quipt Home Medical
| Age | 60 |
| Address | 1019 Town Drive, Wilder, KY, United States, 41076 |
| Phone | 859 878 2220 |
| Web | https://quipthomemedical.com |
Thomas Roehrig Latest Insider Activity
Tracking and analyzing the buying and selling activities of Thomas Roehrig against Quipt Home stock is an integral part of due diligence when investing in Quipt Home. Thomas Roehrig insider activity provides valuable insight into whether Quipt Home is net buyers or sellers over its current business cycle. Note, Quipt Home insiders must abide by specific rules, including filing SEC forms every time they buy or sell Quipt Home'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Thomas Roehrig over six months ago Disposition of 375 shares by Thomas Roehrig of Quipt Home subject to Rule 16b-3 | ||
Thomas Roehrig over a year ago Insider Trading |
Quipt Home Management Efficiency
As of the 3rd of February 2026, Return On Tangible Assets is likely to drop to -0.04. In addition to that, Return On Capital Employed is likely to grow to -0.01. At this time, Quipt Home's Tangible Asset Value is very stable compared to the past year. As of the 3rd of February 2026, Intangibles To Total Assets is likely to grow to 0.43, while Other Assets are likely to drop about 223.5 K. Quipt Home's management efficiency ratios could be used to measure how well Quipt Home manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Brian Walsh | HLS Therapeutics | N/A | |
| Jordan MD | Satellos Bioscience | 46 | |
| Davide Guggi | Helix BioPharma Corp | N/A | |
| Desiree Chan | Satellos Bioscience | N/A | |
| MBA BSCPT | Cardiol Therapeutics Class | N/A | |
| DMIN BSc | ZEN Graphene Solutions | N/A | |
| Helen Middleton | Helix BioPharma Corp | N/A | |
| Scott Carroll | Cannara Biotech | N/A | |
| Veronika Kandziora | Helix BioPharma Corp | N/A | |
| Brian Sherman | Cannara Biotech | N/A | |
| CBV CA | Medicenna Therapeutics Corp | 53 | |
| Robert CFA | Satellos Bioscience | N/A | |
| James Murphy | Helix BioPharma Corp | 68 | |
| Thomas MD | Helix BioPharma Corp | N/A | |
| Courtney Wells | Satellos Bioscience | N/A | |
| Christof Boehler | Helix BioPharma Corp | N/A | |
| Ryan Mitchell | Satellos Bioscience | N/A | |
| Andrew MD | Cardiol Therapeutics Class | 64 | |
| David Abitbol | Cannara Biotech | N/A | |
| Bsc BSc | Satellos Bioscience | 66 | |
| MPH MD | Satellos Bioscience | 51 | |
Management Performance
| Return On Equity | -0.0965 | ||||
| Return On Asset | -0.01 |
Quipt Home Medical Leadership Team
Elected by the shareholders, the Quipt Home's board of directors comprises two types of representatives: Quipt Home inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Quipt. The board's role is to monitor Quipt Home's management team and ensure that shareholders' interests are well served. Quipt Home's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Quipt Home's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hardik Mehta, Chief Officer | ||
| William Zehnder, Chief Relations | ||
| Robert LLB, Corporate Secretary | ||
| Mark Miles, Vice Technology | ||
| David Bachelder, Executive Operations | ||
| Gregory Crawford, President Chairman | ||
| Cole Stevens, Vice Development | ||
| Thomas Roehrig, Executive Finance | ||
| Patrick Gamble, Executive Operations |
Quipt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Quipt Home a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0965 | ||||
| Return On Asset | -0.01 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 357.15 M | ||||
| Shares Outstanding | 44.33 M | ||||
| Shares Owned By Insiders | 21.70 % | ||||
| Shares Owned By Institutions | 54.67 % | ||||
| Number Of Shares Shorted | 731 K | ||||
| Price To Book | 1.56 X |
Pair Trading with Quipt Home
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Quipt Home position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quipt Home will appreciate offsetting losses from the drop in the long position's value.Moving together with Quipt Stock
Moving against Quipt Stock
The ability to find closely correlated positions to Quipt Home could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Quipt Home when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Quipt Home - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Quipt Home Medical to buy it.
The correlation of Quipt Home is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Quipt Home moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Quipt Home Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Quipt Home can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quipt Home Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.